Tandem Diabetes Care Inc (NASDAQ: TNDM) stock closed at $21.75 on 2/27/25 after a major decline of -35.2%. Moreover, this decline was accompanied by exceptionally high trading volume at 964% of normal. The stock has […]
For its first fiscal quarter (ending January 31), Royal Bank of Canada (NYSE: RY) has reported a 42% increase in E.P.S. from $2.50 a year ago to $3.54 in the current quarter. E.P.S. were $12.30 […]
RadNet Inc (NASDAQ: RDNT) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.07 versus a loss $-0.03 for the same period a year ago — a decline of -333%. For the […]
PENN Entertainment Inc (NASDAQ: PENN) has reported E.P.S. of $-0.88 for its fourth fiscal quarter (ending December 31) versus $-2.37 for the same period a year ago — a decline of -63%. For the latest […]
NovoCure Ltd (NASDAQ: NVCR) stock closed at $19.23 on 2/27/25 after a major decline of -12.4%. Moreover, this decline was accompanied by exceptionally high trading volume at 312% of normal. The stock has declined -11.8% […]
Nexstar Media Group Inc. (NASDAQ: NXST) has reported E.P.S. of $7.68 for its fourth fiscal quarter (ending December 31) versus $3.36 for the same period a year ago — an increase of 129%. For the […]
Ligand Pharmaceuticals Inc (NASDAQ: LGND) has reported E.P.S. of $-1.64 for its fourth fiscal quarter (ending December 31) versus $1.04 for the same period a year ago — a decline of -258%. For the latest […]
Essential Utilities Inc (NYSE: WTRG) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.67 versus $0.50 for the same period a year ago — an increase of 34%. For the latest […]
Embraer SA (NYSE: ERJ) stock closed at $47.50 on 2/27/25 after a major increase of 10.7%. Moreover, this advance was accompanied by exceptionally high trading volume at 548% of normal. The stock has risen 11.1% […]
Cytokinetics Inc (NASDAQ: CYTK) has reported a loss for its fourth fiscal quarter (ending December 31) of $-1.26 versus a loss $-1.38 for the same period a year ago — a decline of -9%. For […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research